{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T02:02:10Z","timestamp":1760061730169},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2014,4,30]],"date-time":"2014-04-30T00:00:00Z","timestamp":1398816000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1245\/s10434-014-3710-x","type":"journal-article","created":{"date-parts":[[2014,4,29]],"date-time":"2014-04-29T12:36:41Z","timestamp":1398775001000},"page":"3628-3637","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Identification of Risk and Prognostic Factors for Patients with Clonorchiasis-Associated Intrahepatic Cholangiocarcinoma"],"prefix":"10.1245","volume":"21","author":[{"given":"Guo-Wei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Hua","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-Ping","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,30]]},"reference":[{"key":"3710_CR1","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.idc.2010.07.006","volume":"24","author":"C Braconi","year":"2010","unstructured":"Braconi C, Patel T. Cholangiocarcinoma: new insights into disease pathogenesis and biology. Infect Dis Clin North Am. 2010;24:871\u201384.","journal-title":"Infect Dis Clin North Am."},{"key":"3710_CR2","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1053\/jhep.2001.25087","volume":"33","author":"T Patel","year":"2001","unstructured":"Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology. 2001;33:1353\u20137.","journal-title":"Hepatology."},{"key":"3710_CR3","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1093\/annonc\/mds652","volume":"24","author":"P Bertuccio","year":"2013","unstructured":"Bertuccio P, Bosetti C, Levi F, Decarli A, Negri E, La Vecchia C. A comparison of trends in mortality from primary liver cancer and intrahepatic cholangiocarcinoma in Europe. Ann Oncol. 2013;24:1667\u201374.","journal-title":"Ann Oncol."},{"key":"3710_CR4","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.gcb.2010.01.008","volume":"34","author":"C Martel de","year":"2010","unstructured":"de Martel C, Plummer M, Franceschi S. Cholangiocarcinoma: descriptive epidemiology and risk factors. Gastroenterol Clin Biol. 2010;34:173\u201380.","journal-title":"Gastroenterol Clin Biol."},{"key":"3710_CR5","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1046\/j.1365-2168.2002.02143.x","volume":"89","author":"P Watanapa","year":"2002","unstructured":"Watanapa P, Watanapa WB. Liver fluke\u2013associated cholangiocarcinoma. Br J Surg. 2002;89:962\u201370.","journal-title":"Br J Surg."},{"key":"3710_CR6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/fpd.2012.1253","volume":"10","author":"O Pitaksakulrat","year":"2013","unstructured":"Pitaksakulrat O, Sithithaworn P, Laoprom N, Laha T, Petney TN, Andrews RH. A cross-sectional study on the potential transmission of the carcinogenic liver fluke Opisthorchis viverrini and other fishborne zoonotic trematodes by aquaculture fish. Foodborne Pathog Dis. 2013;10:35\u201341.","journal-title":"Foodborne Pathog Dis."},{"key":"3710_CR7","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1473-3099(11)70294-8","volume":"12","author":"T F\u00fcrst","year":"2012","unstructured":"F\u00fcrst T, Keiser J, Utzinger J. Global burden of human food-borne trematodiasis: a systematic review and meta-analysis. Lancet Infect Dis. 2012;12:210\u201321.","journal-title":"Lancet Infect Dis."},{"key":"3710_CR8","first-page":"291","volume":"25","author":"YY Fang","year":"1994","unstructured":"Fang YY. Epidemiologic characteristics of Clonorchiasis sinensis in Guandong province, China. Southeast Asian J Trop Med Public Health. 1994;25:291\u20135.","journal-title":"Southeast Asian J Trop Med Public Health."},{"key":"3710_CR9","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/hep.22310","volume":"48","author":"B Blechacz","year":"2008","unstructured":"Blechacz B, Gores GJ. Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology. 2008;48:308\u201321.","journal-title":"Hepatology."},{"key":"3710_CR10","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.3892\/or.2013.2290","volume":"29","author":"R Dhanasekaran","year":"2013","unstructured":"Dhanasekaran R, Hemming AW, Zendejas I, et al. Treatment outcomes and prognostic factors of intrahepatic cholangiocarcinoma. Oncol Rep. 2013;29:1259\u201367.","journal-title":"Oncol Rep."},{"key":"3710_CR11","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00432-009-0547-y","volume":"135","author":"XD Zhou","year":"2009","unstructured":"Zhou XD, Tang ZY, Fan J, et al. Intrahepatic cholangiocarcinoma: report of 272 patients compared with 5,829 patients with hepatocellular carcinoma. J Cancer Res Clin Oncol. 2009;135:1073\u201380.","journal-title":"J Cancer Res Clin Oncol."},{"key":"3710_CR12","unstructured":"Stagg RJ. Intrahepatic cholangiocarcinoma. In: Helms RA, Quan DJ, editors. Textbook of therapeutics: drug and disease management. 8th ed. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 2380."},{"key":"3710_CR13","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3855\/jidc.819","volume":"4","author":"V Samaras","year":"2010","unstructured":"Samaras V, Rafailidis PI, Mourtzoukou EG, Peppas G, Falagas ME. Chronic bacterial and parasitic infections and cancer: a review. J Infect Dev Ctries. 2010;4:267\u201381.","journal-title":"J Infect Dev Ctries."},{"key":"3710_CR14","first-page":"118","volume":"5","author":"P Srivatanakul","year":"2004","unstructured":"Srivatanakul P, Sriplung H, Deerasamee S. Epidemiology of liver cancer: an overview. Asian Pac J Cancer Prev. 2004;5:118\u201325.","journal-title":"Asian Pac J Cancer Prev."},{"key":"3710_CR15","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1371\/journal.pmed.0040201","volume":"4","author":"B Sripa","year":"2007","unstructured":"Sripa B, Kaewkes S, Sithithaworn P, et al. Liver fluke induces cholangiocarcinoma. PLoS Med. 2007;4:e201.","journal-title":"PLoS Med."},{"key":"3710_CR16","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.pt.2012.07.006","volume":"28","author":"B Sripa","year":"2012","unstructured":"Sripa B, Brindley PJ, Mulvenna J, et al. The tumorigenic liver fluke Opisthorchis viverrini\u2014multiple pathways to cancer. Trends Parasitol. 2012;28:395\u2013407.","journal-title":"Trends Parasitol."},{"key":"3710_CR17","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.7314\/APJCP.2012.13.5.1963","volume":"13","author":"Q Wu","year":"2012","unstructured":"Wu Q, He XD, Yu L, Liu W, Tao LY. The metabolic syndrome and risk factors for biliary tract cancer: a case-control study in China. Asian Pac J Cancer Prev. 2012;13:1963\u20139.","journal-title":"Asian Pac J Cancer Prev."},{"key":"3710_CR18","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1245\/s10434-010-1458-5","volume":"18","author":"NF Peng","year":"2011","unstructured":"Peng NF, Li LQ, Qin X, et al. Evaluation of risk factors and clinicopathologic features for intrahepatic cholangiocarcinoma in Southern China: a possible role of hepatitis B virus. Ann Surg Oncol. 2011;18:1258\u201366.","journal-title":"Ann Surg Oncol."},{"key":"3710_CR19","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s00595-011-4517-z","volume":"41","author":"M Yamamoto","year":"2011","unstructured":"Yamamoto M, Ariizumi S. Surgical outcomes of intrahepatic cholangiocarcinoma. Surg Today. 2011;41:896\u2013902.","journal-title":"Surg Today."},{"key":"3710_CR20","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/jso.20792","volume":"96","author":"K Shimada","year":"2007","unstructured":"Shimada K, Sano T, Sakamoto Y, Esaki M, Kosuge T, Ojima H. Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases. J Surg Oncol. 2007;96:160\u20135.","journal-title":"J Surg Oncol."},{"key":"3710_CR21","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.sla.0000217639.10331.47","volume":"244","author":"H Witzigmann","year":"2006","unstructured":"Witzigmann H, Berr F, Ringel U, et al. Surgical and palliative management and outcome in 184 patients with hilar cholangiocarcinoma: palliative photodynamic therapy plus stenting is comparable to r1\/r2 resection. Ann Surg. 2006;244:230\u20139.","journal-title":"Ann Surg."},{"key":"3710_CR22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S1001-9294(09)60011-0","volume":"23","author":"XR He","year":"2008","unstructured":"He XR, Wu XP. Difference in biological characteristics and sensitivity to chemotherapy and radiotherapy between intrahepatic and extrahepatic cholangiocarcinoma cells in vitro. Chin Med Sci J. 2008;23:54\u20139.","journal-title":"Chin Med Sci J."},{"key":"3710_CR23","doi-asserted-by":"crossref","first-page":"4023","DOI":"10.1016\/j.transproceed.2009.11.001","volume":"41","author":"H Petrowsky","year":"2009","unstructured":"Petrowsky H, Hong JC. Current surgical management of hilar and intrahepatic cholangiocarcinoma: the role of resection and orthotopic liver transplantation. Transplant Proc. 2009;41:4023\u201335.","journal-title":"Transplant Proc."},{"key":"3710_CR24","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1634\/theoncologist.2012-0432","volume":"17","author":"AX Zhu","year":"2012","unstructured":"Zhu AX, Knox JJ. Adjuvant therapy for intrahepatic cholangiocarcinoma: the debate continues. Oncologist. 2012;17:1504\u20137.","journal-title":"Oncologist."},{"key":"3710_CR25","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1200\/JCO.2011.40.5381","volume":"30","author":"AM Horgan","year":"2012","unstructured":"Horgan AM, Amir E, Walter T, Knox JJ. Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. J Clin Oncol. 2012;30:1934\u201340.","journal-title":"J Clin Oncol."},{"key":"3710_CR26","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1477-2574.2012.00489.x","volume":"14","author":"SB Fisher","year":"2012","unstructured":"Fisher SB, Patel SH, Kooby DA, et al. Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multi-institution analysis. HPB (Oxford). 2012;14:514\u201322.","journal-title":"HPB (Oxford)."},{"key":"3710_CR27","author":"T Li","year":"2013","unstructured":"Li T, Qin LX, Zhou J, et al. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection. Liver Int. 2013. doi: 10.1111\/liv.12364","journal-title":"Liver Int."},{"key":"3710_CR28","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4240\/wjgs.v5.i6.178","volume":"5","author":"AK Arrington","year":"2013","unstructured":"Arrington AK, Nelson RA, Falor A, et al. Impact of medical and surgical intervention on survival in patients with cholangiocarcinoma. World J Gastrointest Surg. 2013;5:178\u201386.","journal-title":"World J Gastrointest Surg."},{"key":"3710_CR29","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1002\/cncr.25712","volume":"117","author":"O Farges","year":"2011","unstructured":"Farges O, Fuks D, Le Treut YP, et al. AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: by the FC-IHCC-2009 study group. Cancer. 2011;117:2170\u20137.","journal-title":"Cancer."},{"key":"3710_CR30","first-page":"2353","volume":"28","author":"Y Yamashita","year":"2008","unstructured":"Yamashita Y, Taketomi A, Morita K, et al. The impact of surgical treatment and poor prognostic factors for patients with intrahepatic cholangiocarcinoma: retrospective analysis of 60 patients. Anticancer Res. 2008;28:2353\u20139.","journal-title":"Anticancer Res."},{"key":"3710_CR31","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.surg.2012.12.005","volume":"153","author":"O Hyder","year":"2013","unstructured":"Hyder O, Hatzaras I, Sotiropoulos GC, et al. Recurrence after operative management of intrahepatic cholangiocarcinoma. Surgery. 2013;153:811\u20138.","journal-title":"Surgery."},{"key":"3710_CR32","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/bjs.8953","volume":"99","author":"L Sulpice","year":"2012","unstructured":"Sulpice L, Rayar M, Boucher E, Pracht M, Meunier B, Boudjema K. Treatment of recurrent intrahepatic cholangiocarcinoma. Br J Surg. 2012;99:1711\u20137.","journal-title":"Br J Surg."},{"key":"3710_CR33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1155\/2013\/196412","volume":"34","author":"G Malaguarnera","year":"2013","unstructured":"Malaguarnera G, Paladina I, Giordano M, Malaguarnera M, Bertino G, Berretta M. Serum markers of intrahepatic cholangiocarcinoma. Dis Markers. 2013;34:219\u201328.","journal-title":"Dis Markers."},{"key":"3710_CR34","first-page":"2337","volume":"54","author":"A Nanashima","year":"2007","unstructured":"Nanashima A, Sumida Y, Abo T, et al. Patient outcome and prognostic factors in intrahepatic cholangiocarcinoma after hepatectomy. Hepatogastroenterology. 2007;54:2337\u201342.","journal-title":"Hepatogastroenterology."},{"key":"3710_CR35","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1007\/s11605-010-1203-1","volume":"14","author":"A Saxena","year":"2010","unstructured":"Saxena A, Chua TC, Sarkar A, Chu F, Morris DL. Clinicopathologic and treatment-related factors influencing recurrence and survival after hepatic resection of intrahepatic cholangiocarcinoma: a 19-year experience from an established Australian hepatobiliary unit. J Gastrointest Surg. 2010;14:1128\u201338.","journal-title":"J Gastrointest Surg."},{"key":"3710_CR36","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1245\/s10434-007-9650-y","volume":"15","author":"T Uenishi","year":"2008","unstructured":"Uenishi T, Yamazaki O, Tanaka H, et al. Serum cytokeratin 19 fragment (CYFRA21-1) as a prognostic factor in intrahepatic cholangiocarcinoma. Ann Surg Oncol. 2008;15:583\u20139.","journal-title":"Ann Surg Oncol."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-3710-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-014-3710-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-014-3710-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,9]],"date-time":"2019-08-09T20:26:04Z","timestamp":1565382364000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-014-3710-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,30]]},"references-count":36,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["3710"],"URL":"https:\/\/doi.org\/10.1245\/s10434-014-3710-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,30]]}}}